Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 Aug 2018

Jang Bum-Sup, Kim In Ah

Abstract excerpt

PURPOSE: Identifying predictive factors for the clinical outcome of patients with lower grade gliomas following radiotherapy could help optimize patient treatments. Here, we investigate the predictive efficacy of both a previously identified "31-gene signature" and programmed death ligand-1 (PD-L1) expression. MATERIAL AND METHODS: We identified 511 patients with lower grade glioma (Grade 2 and 3) in The Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Proportional Hazards Models

Share to Radiation Tolerance

Source

Identifiers

PMID: 29784449
DOI: 10.1016/j.radonc.2018.05.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.PMID 29784449Read ↗

A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas DatasetSemantic proximity Read ↗

The Development and Validation of a Novel 71-Gene Signature for Risk Stratification and Prognosis in Lower Grade GliomaSemantic proximity Read ↗

Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response PredictionSemantic proximity Read ↗

A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) datasetSemantic proximity Read ↗

Classifying lower grade glioma cases according to whole genome gene expressionSemantic proximity Read ↗

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade gliomaSemantic proximity Read ↗

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaSemantic proximity Read ↗

Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade gliomaSemantic proximity Read ↗

EGFR mutation: a prognostic factor associated with immune infiltration in lower-grade glioma.Semantic proximity Read ↗

Exploration to Identify Radiosensitive Genes in PD-L1 Expression and PD-1 check Point Pathway in CancerSemantic proximity Read ↗

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.Semantic proximity Read ↗

Variability in Radiotherapy Outcomes Across Cancer Types: A Comparative Study of Glioblastoma Multiforme and Low-Grade GliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.